Charles D. Goodwin II, Chief Executive Officer at Apyx Medical (NASDAQ:APYX), reported a large insider buy on November 15, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that II purchased 50,000 shares of Apyx Medical. The total transaction amounted to $78,500.
Apyx Medical shares are trading up 2.68% at $1.53 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, ...